New and future developments will improve many aspects of therapeutic corneal collagen cross-linking
Miltos Balidis | | Quick Read
Corneal collagen cross-linking (CXL) is a successful, reliable and reproducible procedure with a long history already. But I do have a wish list for how I would like to improve CXL – and the good news is that clinical investigation is already well underway for many of the items on my wish list. We could start by making it more comfortable for patients than it is today.
We could improve the efficacy of the procedure by targeting specific areas of the cornea in a more customized way. And finally, we may be able to improve the reproducibility of the procedure by better mapping and treating corneal biomechanical changes, rather than just the effects of the disease. Each of these improvements builds on the previous gains.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine